KPTI

Karyopharm Therapeutics Inc

10.21

Jun 26 • 04:00PM ET +0.75 (7.93%)

Healthcare Biotechnology USA Micro NASD

Peers: OABI CAMP CNTX HUMA RNA TENX TNXP UNCY WHWK MIST

| Held by: VTI VXF IWC PRFZ QQQS TMED BTEC CHNA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-15.09	Insider Own	13.55%	Shs Outstand	22.54M	Perf Week	13.19%
Market Cap	231.39M	Forward P/E	-	EPS next Y	-3.12	Insider Trans	-0.88%	Shs Float	19.59M	Perf Month	13.70%
Enterprise Value	371.41M	PEG	-	EPS next Q	-1.31	Inst Own	77.12%	Short Float	28.51%	Perf Quarter	83.30%
Income	-194.97M	P/S	1.53	EPS this Y	77.24%	Inst Trans	8.95%	Short Ratio	10.73	Perf Half Y	37.23%
Sales	151.12M	P/B	-	EPS next Y	23.53%	ROA	-150.48%	Short Interest	5.59M	Perf YTD	38.72%
Book/sh	-11.78	P/C	2.55	EPS next 5Y	55.85%	ROE	-	52W High	10.99 -7.10%	Perf Year	127.39%
Cash/sh	4.01	P/FCF	-	EPS past 3/5Y	16.03% 15.19%	ROIC	-	52W Low	3.65 179.70%	Perf 3Y	-64.36%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-2.39% 6.21%	Gross Margin	95.88%	Volatility	8.49% 8.13%	Perf 5Y	-93.81%
Dividend TTM	-	EV/Sales	2.46	EPS Y/Y TTM	-102.63%	Oper. Margin	-55.73%	ATR (14)	0.74	Perf 10Y	-90.95%
Dividend Ex-Date	-	Quick Ratio	1.05	Sales Y/Y TTM	6.33%	Profit Margin	-129.02%	RSI (14)	61.65	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	1.08	EPS Q/Q	55.38%	SMA20	10.56%	Beta	0.80	Target Price	15.00
Payout	-	Debt/Eq	-	Sales Q/Q	16.83%	SMA50	14.97%	Rel Volume	6.17	Prev Close	9.46
Employees	228	LT Debt/Eq	-	Earnings	May 14 BMO	SMA200	38.94%	Avg Volume	520.58K	Price	10.21
IPO	Nov 06, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.50% 11.68%	Trades		Volume	3,214,091	Change	7.93%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)